For Health Plans
Better metabolic health outcomes at scale
Our Digital Twin™ technology and expert care team work together to prevent and improve chronic conditions like type 2 diabetes while reducing health plan costs.
73%
eliminated medications, including injections
14 lbs
lost in 6 months (with no weight rebound)
2.2
point drop in A1C
70%
reduced inflammation
77%
improved insulin resistance (in those with type 2 diabetes)
67%
reduced visceral fat
Meet your
Digital Twin™
The Digital Twin™ is a real-time model of a member’s unique metabolism that analyzes data from wearable devices to help them make informed choices in their daily life.
Validated by clinical research
Twin members continue losing weight after stopping GLP-1s
Twin members2
continue to lose ~6% of body weight on average
Patients without Twin
gain back ~13%
1. Based on the semaglutide (Ozempic) clinical trial https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9542252/#dom14725-supitem-0001) N=228
2. Inclusive of Active Commercial Members >=52 weeks in the Twin T2D Program who stopped GLP-1 >=52 weeks prior to the analysis and had a start BMI >=27
We stand behind our solutions
We’re so confident in the efficacy of our programs that our metabolic health benefits are offered fully at-risk. These programs are based upon the highest quality RCT research, which has been peer-reviewed and published in leading journals.
*Outcomes from a Twin self-insured employer partner
19%
Eligible population activated
within the first year
$8.4k
Annual savings per member
with at least 1 high-cost medication
$3.2M
Projected pharmacy savings
annualized across all members with 1 or more high-cost meds*
Results that speak for themselves
77%
Members improved insulin resistance (HOMA2IR)
Among T2D members
67%
% Members improved visceral fat
70%
% Members improved inflammation
Among baseline hsCRP >3
83%
% Members A1c No Longer Uncontrolled
Avg among baseline A1c 9.0+
-2.2
A1c Reduction
Avg among baseline A1c 8.0+
-1.1
A1c Reduction
Avg among baseline A1c
-17 lbs
Weight Loss Achieved
Avg among BMI 40+
-14 lbs
Weight Loss Achieved
Avg among BMI 30+
75%
% Members Lost Weight
73%
1+ High Cost Medications Eliminated
-14 lbs
Weight Loss Achieved
Avg among BMI 30+
75%
% Members lost weight
66%
% Members Improved Hypertension
81%
% Members Improved Cholesterol
Among TG/HDL >=4
77%
% Members Improved Framingham Risk Score
Among FRS 20+
69%
% Members Improved Fatty Liver (MAFLD)
86%
% Members Improved Kidney Function (eGFR)
Among Prediabetes and/or Obesity members, eGFR >90
65%
% Members Improved Kidney Function (eGFR)
Among all members eGFR >90
Trusted by leading companies
Start changing
outcomes & lives
Discover how Twin Health’s evidence-based, as-risk programs help employees and health plan members thrive.
